Guidelines for Diagnosis and Management of Gestational Diabetes Mellitus (GDM) in India
The diagnosis and management of Gestational Diabetes Mellitus (GDM) in India follows two main approaches: the one-step and two-step strategies, with the one-step approach being increasingly preferred due to its ability to identify more cases of GDM and potentially reduce adverse pregnancy outcomes.
Diagnostic Approaches for GDM
One-Step Approach
- The one-step approach uses a 75g oral glucose tolerance test (OGTT) with plasma glucose measurements taken when fasting and at 1 and 2 hours, performed between 24-28 weeks of gestation 1, 2
- Diagnosis is made when any of the following plasma glucose values are met or exceeded:
- This approach identifies approximately 15-20% of pregnant women with GDM, which is 2-3 times more cases than the two-step approach 1, 2
Two-Step Approach
- Step 1: Perform a 50g glucose load test (GLT) without fasting, with plasma glucose measurement at 1 hour, at 24-28 weeks of gestation 1
- If the plasma glucose level at 1 hour is ≥130,135, or 140 mg/dL (7.2,7.5, or 7.8 mmol/L), proceed to a 100g OGTT 1, 3
- Step 2: The 100g OGTT should be performed after fasting 1
- Diagnosis is made when at least two of the following plasma glucose levels are met or exceeded:
- Fasting: 95 mg/dL (5.3 mmol/L)
- 1 hour: 180 mg/dL (10.0 mmol/L)
- 2 hour: 155 mg/dL (8.6 mmol/L)
- 3 hour: 140 mg/dL (7.8 mmol/L) 1
- The American College of Obstetricians and Gynecologists notes that one elevated value can be used for diagnosis 1
DIPSI Approach (Specific to India)
- The Diabetes in Pregnancy Study Group India (DIPSI) recommends a non-fasting OGTT with 75g of glucose with a cut-off of ≥140 mg/dl after 2 hours 4
- This approach is more practical in the Indian context as it doesn't require women to come fasting 4
Early Screening Recommendations
- Risk assessment for GDM should be undertaken at the first prenatal visit 1, 5
- Women with high-risk characteristics (marked obesity, personal history of GDM, glycosuria, strong family history of diabetes, or high-risk ethnicity) should undergo glucose testing as soon as feasible 1, 5
- If initial screening is negative, high-risk women should be retested between 24-28 weeks of gestation 1, 5
- Women of average risk should have testing undertaken at 24-28 weeks of gestation 1, 3
Management of GDM
Lifestyle Modifications
- Nutritional therapy with calorie restriction and a low glycemic index diet is recommended as first-line treatment to avoid postprandial hyperglycemia and reduce insulin resistance 6
- Regular exercise is recommended as part of lifestyle modifications 6
- Blood glucose levels, HbA1c levels, and ketonuria should be monitored to analyze the efficacy of conservative management 6
Pharmacological Therapy
- Pharmacological treatment is initiated if conservative strategies fail to provide expected glucose levels during follow-ups 6
- Insulin has traditionally been the first choice for treatment of diabetes during pregnancy 6
- Metformin is increasingly being used when insulin cannot be prescribed, although up to 46% of women may require additional insulin to maintain expected blood glucose levels 6
Postpartum Follow-up
- Women with GDM should be screened for persistent diabetes at 4-12 weeks postpartum using a 75g OGTT 1, 3
- Women with a history of GDM should have lifelong screening for diabetes or prediabetes at least every 3 years 1, 3
- Women found to have prediabetes should receive intensive lifestyle interventions or metformin to prevent diabetes 1, 3
Clinical Considerations and Controversies
- The one-step approach identifies more women with GDM but its clinical benefit in reducing adverse pregnancy outcomes remains controversial 7
- Women diagnosed with GDM by the one-step approach have a 3.4-fold higher risk of developing prediabetes and type 2 diabetes later in life 5
- The IADPSG criteria (one-step approach) is the only outcome-based criteria and has the advantage of simplicity in execution, being more patient-friendly, and accurate in diagnosis 4
- Given the diversity and variability of the Indian population, further comparative studies are required on different diagnostic criteria in relation to adverse pregnancy outcomes 4